摘要 |
<p>The present invention provides a method of preventing or reducing the severity of a stress-associated condition in a subject by systemically administering to the subject an effective amount of brimonidine or a pharmaceutically acceptable salt, ester, amide, sterioisomer or racemic mixture thereof. Stress-associated conditions that can be treated according to a method of the invention include, but are not limited to, dyspepsia, tachycardias other than tachycardia associated with myocardial ischemia, panic attack, non-inflammatory dermatogical conditions, disorders of muscle contraction, sensory hypersensitivity associated with migraine, and behavioral disorders.</p> |
申请人 |
ALLERGAN, INC.;GIL, DANIEL, W.;WHITCUP, SCOTT, M.;BRIN, MITCHELL, F.;DONELLO, JOHN, E. |
发明人 |
GIL, DANIEL, W.;WHITCUP, SCOTT, M.;BRIN, MITCHELL, F.;DONELLO, JOHN, E. |